Article 05 Aug 2021 Ushering In A New Era: FDA Approves First Interchangeable Biosimilar United States Healthcare
Article 14 Jun 2021 HHS Issues Buprenorphine Practice Guidelines As Study Confirms Access Barriers United States Healthcare
Article 07 May 2021 FDA Ups The Ante And Sends First Notice Of Noncompliance For Failure To Submit Clinical Trial Results United States Healthcare
Article 29 Mar 2021 CBD Regulatory Enforcement Continues With Over-the-Counter CBD Pain Relief Products United States Healthcare
Article 10 Feb 2021 Working Together, FDA, NTIA, And Domain Registries Take Down 30 Websites Illegally Selling Opioids United States Healthcare
Article 29 Jan 2021 Recent Amendments To The FDA Laws Attempt To Clarify And Improve Existing Systems United States Healthcare
Article 26 Nov 2020 Are Speaker Programs A Thing Of The Past? OIG's Fraud Alert Indicates It Thinks They Should Be United States Healthcare
Article 14 Nov 2020 DEA Releases Long-Awaited Suspicious Orders Proposed Rule United States Healthcare
Video 04 Sep 2020 Introduction To The Due Diligence Process, Second Edition (Video) United States Healthcare
Article 25 Aug 2020 OTC Monograph Reform: Key Takeaways And What Industry Can Expect United States Healthcare